C3.ai Form 4: 32,309-share option; 12.5% quarterly vesting
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
C3.ai filed a Form 4 reporting a director stock option for 32,309 shares of Class A common stock at an exercise price of $19.16, granted on October 3, 2025. The option expires on October 2, 2035.
Vesting begins October 3, 2025: 12.5% of the option vests on the last day of each fiscal quarter in which the director attends the regularly scheduled board meeting in person over two years. Any quarter missed suspends that tranche; suspended tranches vest only after the second anniversary if subsequent attendance requirements are met.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
MCCAFFERY MICHAEL G
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 32,309 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 32,309 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What did C3.ai (AI) disclose in this Form 4?
A director received a stock option for 32,309 Class A shares at an exercise price of $19.16, granted on October 3, 2025.
What is the vesting schedule for the C3.ai (AI) director option?
Starting October 3, 2025, 12.5% vests on the last day of each fiscal quarter the director attends the regularly scheduled board meeting in person over two years.
What happens if the director misses a qualifying board meeting?
That quarter’s vesting is suspended; suspended tranches vest only after the second anniversary if subsequent attendance requirements are satisfied.
When does the C3.ai (AI) option expire?
The option expires on October 2, 2035.
How many derivative securities are beneficially owned after the transaction?
The filing reports 32,309 derivative securities beneficially owned following the transaction.
What is the reported ownership form for the option?
Ownership is listed as Direct (D).